AI assistant
Sending…
Catheter Precision, Inc. — Director's Dealing 2023
Mar 27, 2023
35479_dirs_2023-03-27_bcce1440-7bfc-4205-8623-b27efb97c4e3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Ra Medical Systems, Inc. (RMED)
CIK: 0001716621
Period of Report: 2023-03-23
Reporting Person: Caruso James Joseph (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-03-23 | Common Stock | C | 1779 | — | Acquired | 1779 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-03-23 | Series X Convertible Preferred Stock | $0 | C | 1.779 | Disposed | Common Stock (7932) | Direct |
Footnotes
F1: This the transaction was the result of the automatic conversion of shares of Series X Preferred upon receipt of stockholder approval.
F2: Each share of preferred stock will automatically convert into 1000 shares of common stock on or after July 9, 2024, if the Company satisfies the initial listing standards of a national securities exchange or has been delisted from the NYSE American.
F3: Series X Convertible Preferred Stock has no expiration date.
More from Catheter Precision, Inc.
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 18
Annual Report
2026
Apr 30
Regulatory Filings
2026
Mar 31
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Director's Dealing
2026
Feb 18
Major Shareholding Notification
2026
Feb 13
Regulatory Filings
2026
Feb 12